Author of Garnering Capital. Founder/Co-Founder of several public drug development companies.
San Juan, Puerto Rico
Joined January 2011
- Tweets1.2K
- Following1.6K
- Followers1.3K
- Likes50
Bill Garner, MD retweeted
Texas State experiments with paying faculty for #invention disclosures - tinyurl.com/yckpfd8w #techtransfer @TXStateUnivSyst
Bill Garner, MD retweeted
BREAKING: The first US polio case in over 9 years happened because they were not vaccinated. They now have paralysis.
I don't know who needs to hear this right now, but vaccines work.
Bill Garner, MD retweeted
Intellia is not for sale. But CEO John Leonard is on the lookout for complementary gene editing tech. @intelliatweets #biotech #geneediting fiercebiotech.com/biotech/in…
Bill Garner, MD retweeted
I just applied to @LatinxVCs GP Showcase.
At @mgvcapitalgroup, we have invested an average of $100k into 16 startups in our first year of operations.
75% have minority founders
56% have at least one female founder
38% have at least one Latinx founder
25% are led by female CEOs
The deadline for Latinx Emerging Managers to apply to the @LatinxVCs GP showcase is Monday night! Make sure to share with any Latinx VCs you know.
latinxvc.typeform.com/GPshow…
Emergency Medicine’s Original Sin - The Atlantic apple.news/A--JNPz2tS6ymZJIK…
Bill Garner, MD retweeted
Congrats to @merchantgrp for the establishment of a new $250m fund dedicated solely to emerging #biotech companies. Check out their write-up in the @FinancialReview this week!
afr.com/street-talk/merchant…
Bill Garner, MD retweeted
We are pleased to announce our listing on the OTCQB market and DTC eligibility, marking our entry into the US financial markets under the symbol "TRYPF". This new listing will allow us to attract new investors passionate about psychedelics.
$TRYP $TRYPF
newsfilecorp.com/release/794…
Bill Garner, MD retweeted
We have submitted the first of many provisional patents aimed at improving the formulation, delivery, and dosing of psychedelics, with the goal of reducing time patients spend in a dissociative state.
$TRYP
newsfilecorp.com/release/777…
Bill Garner, MD retweeted
We are pleased to announce that we have begun the process of manufacturing our psilocybin formulation with Albany Molecular Research.
This is an important milestone in Tryp's drug development process to advance our clinical trials.
$TRYP
newsfilecorp.com/release/745…
Bill Garner, MD retweeted
We are pleased to welcome Dr. Joel Castellanos to our team as a clinical advisor.
Dr. Castellanos is a member of the “Psychedelics and Health Research Initiative” at UC San Diego and will help advance TRP-8802 for neuropathic pain indications.
$TRYP
newsfilecorp.com/release/742…
Bill Garner, MD retweeted
We are pleased to announce we have commenced a collaboration with Dr. Jennifer Miller of the University of Florida to begin a Phase 2a clinical trial for patients suffering from rare and orphan over-eating disorders.
$TRYP
newsfilecorp.com/release/739…
Bill Garner, MD retweeted
We are a pure-play drug development company bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. Learn more:
$TRYP
tryptherapeutics.com/
Bill Garner, MD retweeted
Stay up to date with everything happening at Tryp Therapeutics.
Find the latest news, information on our team, developments within our drug pipeline, and investor information at: tryptherapeutics.com
$TRYP
Bill Garner, MD retweeted
Parece que Pfizer y Moderna se han puesto de acuerdo en hacer sus vacunas totalmente diferentes
❌ Dilución
❌ Volumen a cargar
❌ Posología
❌ Estabilidad
❌ Conservación
❌ N° de dosis
#SeVaALiarParda
#VacunaCOVID19
@StopErroresMed
Bill Garner, MD retweeted
Stay up to date with everything happening at Tryp Therapeutics.
Find the latest news, learn about our team, developments within our drug pipeline and investor information at:
tryptherapeutics.com/
Bill Garner, MD retweeted
We are pleased to announce we have begun trading today, under the symbol $TRYP on the CSE.
newsfilecorp.com/release/705…
Bill Garner, MD retweeted
We’re delighted to report that @RaceOncology was added to the @MSCI_Inc Australia Micro Cap Index in yesterday’s index rebalance. See the full list of index constituency revisions here: bit.ly/2JoZfRv
$RAC #precisiononcology #targetedtherapeutics
Bill Garner, MD retweeted
CEO & MD of @RaceOncology $RAC, Phil Lynch, discusses the benefits of the Company’s new strategy for #Bisantrene at today’s #AGM bit.ly/36puYLD
